Noncoding small RNAs regulate gene expression in all organisms, in some cases through direct association with RNA polymerase (RNAP). Here we report that the mechanism of 6S RNA inhibition of transcription is through specific, stable interactions with the active site of Escherichia coli RNAP that exclude promoter DNA binding. In fact, the DNA-dependent RNAP uses bound 6S RNA as a template for RNA synthesis, producing 14-to 20-nucleotide RNA products (pRNA). These results demonstrate that 6S RNA is functionally engaged in the active site of RNAP. Synthesis of pRNA destabilizes 6S RNA-RNAP complexes leading to release of the pRNA-6S RNA hybrid. In vivo, 6S RNA-directed RNA synthesis occurs during outgrowth from the stationary phase and likely is responsible for liberating RNAP from 6S RNA in response to nutrient availability.
T he majority of noncoding small RNAs (sRNAs) of known function act by forming base pairs with target mRNAs, thereby altering translation or mRNA stability (1) (2) (3) . However, bacterial and eukaryotic RNAs exist that alter gene expression by binding directly to RNA polymerase (RNAP) (1, 4) . The bacterial 6S RNA mediates cellular response to environmental stresses in Escherichia coli when nutrients are limiting (5, 6) . This highly conserved RNA forms a specific, stable complex with the s 70 -containing form of RNAP (Es 70 ), inhibiting transcription at many, although not all, s 70 -dependent promoters (5, 7, 8) . The murine B2 RNA, unrelated to 6S RNA in sequence and structure, has been shown to down-regulate transcription during heat shock. B2 RNA binds RNAP II and blocks isomerization steps that occur during transcription initiation after promoter binding (4) . A crystal structure of a synthetic RNA (FC*) postulated to act similarly to B2, revealed that it binds near the active site of yeast RNAP II (9) .
The conserved secondary structure of 6S RNA is critical for function and features a large, single-stranded bulge within a mostly double-stranded molecule (Fig. 1A) (8, 10) . The similarity of this structure to the melted DNA conformation in the "open complex" formed during transcription initiation suggests that 6S RNA inhibits transcription by competing with promoter DNA binding. To test this hypothesis, Es 70 binding to a DNA promoter was examined in the presence or absence of 6S RNA (11) . Es 70 efficiently bound to duplex DNA containing a consensus promoter (12) . Preincubation of 6S RNA with Es 70 significantly reduced DNA binding, whereas an inactive mutant 6S RNA lacking most of the single-stranded region (M5) (8) had no detectable effect (Fig. 1C) . Furthermore, 6S RNA strongly reduced binding of a single-stranded DNA oligonucleotide that mimics the specific interactions between Es 70 and the nontemplate strand within the open complex (12) (13) (14) , whereas the M5 control did not (Fig. 1D) . These results indicate that 6S RNA inhibits transcription by blocking DNA binding, in contrast to B2 and FC* RNAs, which inhibit transcription at a later step in initiation (4 fig. S1 ). Cleavage was strongest at U44 and A43 of 6S RNA and weaker at neighboring A45, U46, and G42 residues (see Fig. 1A ).
The iron-directed cleavage sites are located within the "bubble" region of 6S RNA and orient 6S RNA relative to Es
70
. The position of the active site within the bubble appears analogous to where transcription initiates in the open complex formed with promoter DNA (see Fig. 1 ). This similarity prompted us to test whether 6S RNA could act as a template for RNA synthesis. Initiation of RNA synthesis can be detected by examining the addition of a single templated nucleotide (corresponding to the +3 position) to a dinucleotide complementary to positions +1 and +2 on the template. 6S RNA directs the addition of cytidine 5´-triphosphate (CTP), but not guanosine 5´-triphosphate (GTP), to ApU ( Fig. 2A  and fig. S2 ). No products were observed in the absence of an RNA template, from the M5 control, or from using ApC to initiate synthesis; this shows that specific RNA synthesis occurs. Tem- plate specificity was confirmed using a mutant 6S RNA; M12 contains an A to G mutation at position 43 and directed addition of CTP to ApC but not to ApU ( Fig. 2A) . Although E. coli RNAP can use RNA as a template for RNA synthesis (16) (17) (18) (19) , this is the first demonstration of RNAP transcribing a physiologically relevant RNA. To determine whether 6S RNA could direct de novo RNA synthesis, 6S RNA:Es 70 complexes were incubated with all four nucleotide triphosphates (NTPs). RNA products (pRNAs) 14 to 20 nucleotides (nt) long were generated when 6S and M12 RNAs were used as templates, whereas incubation with the inactive M5 or in the absence of RNA did not produce products (Fig. 2B) . Analysis of 5′ end-labeled pRNAs revealed that all these products initiate at the U44 template position (fig. S3 ). The longest pRNA is 20 nt in length, which indicates that the enzyme terminates before reaching the end of the 6S RNA template. We speculate that mechanisms limiting pRNA length may be analogous to those that generate a 20-nt primer at the origin of replication of M13 phage DNA (20) and 22-to 30-nt RNA products on singlestranded DNA templates (21, 22) . In both cases, the formation of an extended RNA-DNA hybrid [>9 base pairs (bp)] is postulated to result in largescale RNAP rearrangements, displacement of the 3′ end of the nascent RNA from the active site, and transcription termination (21, 22) .
To test whether 6S RNA templated RNAsynthesis results in release of 6S RNA, 6S RNA:Es 70 complexes with labeled 6S RNA or with labeled pRNA were examined by native gel electrophoresis (Fig. 3A) . fig. S4) , which suggested that s 70 is released during the process of RNA synthesis using 6S RNA as template.
6S RNA-templated synthesis initially appears to follow steps similar to transcription initiation on promoter DNA. However, the transition to longer pRNA synthesis destabilizes 6S RNA:RNAP interactions, in sharp contrast to DNA-directed transcription, which leads to the formation of highly stable DNA-pRNA:core complexes. Although s 70 is released, the 6S RNApRNA:core complex is short-lived or destabilized by heparin, as it is not detected after a 2-min heparin challenge (Fig. 3A, lanes 8 and 10) . Destabilization may be caused by persistent base-pairing of 6S RNA to pRNA as observed when extended RNA:DNA duplexes form on DNA templates lacking nontemplate strands (23) (24) (25) . Although 6S RNA contains a putative nontemplate strand, it is not able to anneal to the template strand, and we speculate that loss of a reannealing driving force in addition to distinct s 70 -6S RNA interactions favor formation of an extended RNA:pRNA hybrid over displacement of nascent pRNA.
To determine if and when RNA synthesis from 6S RNA occurs in vivo, we first tested whether 6S RNA:RNAP complexes could be detected in cell extracts. Two forms of 6S RNA with mobility similar to the free 6S RNA and 6S RNA:Es 70 were detected in extracts from stationary phase cells (Fig. 3B) . Incubation of extract with NTPs resulted in formation of a new complex that migrates similarly to 6S RNA- Samples in (B) and (C) were treated with heparin before native gel electrophoresis. For (B) and (C), endogenous 6S RNA-containing complexes were detected by Northern analysis using a 6S RNA-specific probe. pRNA, which suggests that 6S RNA can be used as a template for transcription in extract. Extract containing samples required heparin treatment to resolve specific complexes on native gels; therefore, 6S RNA-pRNA:core complexes were not observed. Gradient fractionation of a stationary phase extract after incubation with NTPs similarly demonstrated significant release of 6S RNA from Es 70 ( fig. S5 ). The 6S RNA:Es 70 complex is stable in vitro and accumulates to high levels in stationary phase, raising the question of how 6S RNA-RNAP interactions are disrupted when cells reinitiate growth. To test if RNA synthesis could mediate timely 6S RNA release, endogenous 6S RNA complexes were examined in extracts prepared from cells after dilution into rich medium (Fig. 3C) . A 6S RNA complex with mobility suggesting it was 6S RNA-pRNA was detected in extracts from cells 2 to 30 min after dilution. Extracts were not incubated nor NTPs added; therefore, complexes represent those formed in vivo. Addition of an RNAP inhibitor (rifampicin) to the dilution medium prevented 6S RNApRNA complex formation, which demonstrated that its formation requires RNA synthesis. The presence of 6S RNA-pRNA complexes in cells after outgrowth signifies that Es 70 uses 6S RNA as a template for RNA synthesis at this time, consistent with the hypothesis that 6S RNA release from Es 70 could be mediated through this process.
We propose that 6S RNA-templated RNA synthesis occurs in response to the rapid increase in NTP pools upon outgrowth (26) . In vitro RNA synthesis from 6S RNA required higher concentrations of NTPs (>50 mM) than several tested DNA promoters (<1 mM NTPs) ( fig. S6 ), which suggests that transcription from 6S RNA is more sensitive to NTP concentration. Other factors also may affect the relative stability of 6S RNA:Es 70 complexes or may prevent RNA synthesis from 6S RNA, as the 6S RNApRNA complex was observed only early after exit from stationary phase and did not persist through exponential growth.
In addition to freeing RNAP from 6S RNA inhibition, the RNA synthesis reaction likely results in decreased stability of 6S RNA. 6S RNA levels are decreased during outgrowth ( fig. S7 ) and do not reach maximum levels until well after transition into stationary phase (7) . Such decreased stability might be due to increased accessibility of 6S RNA to cellular nucleases on release from RNAP or could be through direct recognition of the 6S RNApRNA duplex. It also is tempting to consider whether the pRNA has a cellular function distinct from the role its synthesis has in 6S RNA release, especially because the template region within 6S RNA is more conserved than the rest of the RNA (8) .
Control of 6S RNA levels and 6S RNAEs 70 interactions in direct response to NTP concentration create a regulatory circuit where release from RNAP and control of stability of the sRNA inhibitor depend on the same features of the RNA required for its inhibitory nature. Precise positioning of 6S RNA in the active site of RNAP blocks DNA promoter binding but allows synthesis-mediated release of 6S RNA. The mechanism of 6S RNA inhibition appears to differ from FC* and B2 RNA, which do not exclude DNA binding within preinitiation complexes (4), which suggests their mechanism of release also will be distinct. However, a common theme for sRNA inhibitors of RNAP may be to exploit inherent properties and activities of the enzyme for its inhibition, as well as for its release from such regulation. Mounting evidence has revealed pathological interactions between HIV and malaria in dually infected patients, but the public health implications of the interplay have remained unclear. A transient almost one-log elevation in HIV viral load occurs during febrile malaria episodes; in addition, susceptibility to malaria is enhanced in HIV-infected patients. A mathematical model applied to a setting in Kenya with an adult population of roughly 200,000 estimated that, since 1980, the disease interaction may have been responsible for 8,500 excess HIV infections and 980,000 excess malaria episodes. Co-infection might also have facilitated the geographic expansion of malaria in areas where HIV prevalence is high. Hence, transient and repeated increases in HIV viral load resulting from recurrent co-infection with malaria may be an important factor in promoting the spread of HIV in sub-Saharan Africa.
Dual Infection with HIV and Malaria
I n Africa, an estimated 40 million people are infected with HIV, resulting in an annual mortality of over 3 million (1), whereas over 500 million clinical Plasmodium falciparum infections occur every year with more than a million malaria-associated deaths (2) . There is considerable geographic overlap between the two diseases, particularly in subSaharan Africa (3), and growing evidence of an interactive pathology (4) (5) (6) (7) (8) (9) (10) . HIV has been shown to increase the risk of malaria infection and the development of clinical malaria, with the greatest impact in immune-suppressed persons (4, 6, (8) (9) (10) . Conversely, malaria has been shown to induce HIV-1 replication in vitro (11) and in vivo (5, 7) . A biological explanation for www.sciencemag.org SCIENCE VOL 314 8 DECEMBER 2006 
